Trial intelligence / Profile preview

Gentamicin Irrigation and Suction Ureteral Access Sheath in RIRS

NCT07655050Recruiting

Sponsor
Hitit University
Start
Jun 2026
Primary completion
Feb 2027
Countries
1
01

Overview

Randomised trial of gentamicin in urinary tract infection (UTI), sepsis and Systemic Inflammatory Response Syndrome (SIRS) (4 arms), sponsored by Hitit University. Primary endpoints: Postoperative Fever at 48 hours, Systemic Inflammatory Response Syndrome at 48 hours and 1 more. Started Jun 2026; status: recruiting.

02

Drugs

gentamicin
03

Conditions

urinary tract infection (UTI)sepsisSystemic Inflammatory Response Syndrome (SIRS)

Beyond the preview

Go deeper on NCT07655050.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07655050.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call